Zoom Logo

Unlocking the Power of Decentralized Drug Distribution: How DDD Can Work for Tuberculosis, Noncommunicable Diseases and Family Planning - Shared screen with speaker view
Longin Gashubije
16:55
HI
Paul Pierre
17:48
Sarah and Moses, please let me know when it is ok to start
Sarah Dixon
17:58
Welcome and thank you for joining us. Feel free to introduce yourself in the chat.
Sarah Dixon
18:09
Go ahead Paul
Edward Oladele
18:12
Edward OladeleFHI 360.
Bhagawan Shrestha
18:15
Hi, This is Bhagawan from EpiC Nepal
catherine michel
18:18
Hello Cathy Michel EpiC MZ
Edward Oladele
18:26
Greetings everyone
Longin Gashubije
18:37
I am Gashubije Longin from Burundi
Edward Oladele
18:51
Edward Oladele, FHI 360>Greetings everyone
Patrick Makelele
18:51
Patrick Makelele -FHI360 Zambia Technical Advisor
MJ Schoemaker
19:09
HI there from MJ Schoemaker at ARC! Thanks for organising this event!!
Makoae Mosothoane
19:58
Makoae Mosothoane, Right to Care Lesotho. Greetings everyons
Tarirai Mavimba
20:17
Tari Mavimba, ZHI (FHI360 sub, Zimbabwe)
Jeanne Marie Francine KAREMERA
21:00
Francine Karemera, FHI 360 Burundi
Nkhosikhona Advocate Dlamini
24:48
Dr Advocate Nkhosikhona Dlamini, ENAP/MOH,Kingdom of eSwatini
Esinath Derera
25:11
Esinath Derera FHI360 Mhuri/imuli Hello everyone
merlin pillay
25:49
Maggie Munsamy: NHI: Technical Specialist , HEAD: CCMDD, Ministry of Health, South Africa
Dennis Osiemo
25:50
Good morning/afternoon, Dennis Osiemo USAID KEA
Dorothy OQUA
26:45
Dorothy Oqua, Howard University Global Initiative Nigeria
Anthony Okoth
27:37
Anthony Okoth, ARC Kenya
Pugie Chimberengwa
27:46
Pugie Chimberengwa; Technical Director-OPHID, Zimbabwe
Samuel Onwubiko
28:46
Onwubiko Samuel, Senior Technical Officer, Achieving Health Nigeria Initiative, Nigeria.
Nyaradzo Muhonde
29:10
Nyaradzo Muhonde, FHI360, Technical Director Mhuri/Imuli
Phil Roberts
29:23
Phil Roberts ,Project Last Mile South Africa
Tarirai Mavimba
32:12
Tari Mavimba, ZHI (FHI360 sub, Zimbabwe)
Phil Roberts
33:18
Phil Roberts ,Project Last Mile South Africa
Johnbaptist Ezenduka
34:28
Ezenduka Johnbaptist (AHNi, Nigeria)
Khesiwe Ncube
34:30
Warm greetings to you all, Khesiwe Ncube , FHI360 -Mhuri/Imuli Project , Zimbabwe
Mazwi Dzapasi
37:14
Mazwi Dzapasi ,Africa Resource Centre, South Africa
morgen muzondo
39:14
Morgen Muzondo, ZHI (FHI360 sub, Zimbabwe)
morgen muzondo
42:09
Morgen Muzondo, ZHI (FHI360 sub, Zimbabwe)
Moses Bateganya
42:21
Moses Bateganya, FHI 360/EpiC
Ashley Greve
42:38
Ashley Greve, USAID/OHA
Nsoh Marius
43:35
Nsoh Marius, Fhi360/ EpiC Cameroon.
Fredrick Mubiru
43:50
Frederick Mubiru FHI 360/ R4S
Robert Makombe
44:15
Robert Makombe, FHI 360/EpiC
Tendai Mazorodze Samushonga
45:00
Tendai Samushonga, ZHI (FHI360 sub, Zimbabwe)
Hafsat Adesina
45:52
Afusat Adesina,Howard UniversitySHARP TO2 project,,Nigeria
Bronwyn Timm
51:00
Bronwyn Timm, Africa Resource Centre
Andrew Maranga
52:13
Andrew Maranga, EpiC Mozambique
James Batuka
01:00:35
James Batuka
Moses Bateganya
01:01:10
There are some questions in the chat and in the Q&A
Moses Bateganya
01:18:01
when sharing in the chat please send to all not just panelists.
Moses Bateganya
01:24:54
ALL: I haven't seen any response to Dr Tran's question on how TB dispensing is happening in the countries participating on the call? If you have any practical experiences please share
Cuc Tran, US CDC
01:28:16
Yes, please share! You are doing great work and we want to learn from you!
Hannah Marqusee
01:30:47
I’m not sure the audience members have speaking permissions
Moses Bateganya
01:31:23
Sara h are people able to unmute?
Sarah Dixon
01:32:17
No but I unmuted Dr. Unamba but they haven't spoken
Sarah Dixon
01:32:50
Fred only had two slides left so let's use the rest of the time for Q+A
Sarah Dixon
01:34:21
Fred it back so let's engage him in the Q+A please
Longin Gashubije
01:36:33
Sorry I have to participate in another meeting. Congratulation to the team I wish the community distribution will solve the issue of workload and improuve access without harming the users.
Moses Bateganya
01:38:16
Fred, based on your experience do you think drug shops can distribute ART safely? if so what would we need to do to use them?
Patrick Makelele
01:39:50
Hello team,I wanted to ask the following question. I wanted to find out if we needed to have policy change and come up with another policy framework at national level. Before DSD being scaled up we had to go through these processes at national level . Do we need to do the same to include other product different from ARVs we advocated DSD for?
Nicholas Kisyeri
01:40:13
In Edwatini: Drug sensitive TB Medicine is dispensed in the similar manner as the HIV Medicine. It is coordinated by nurses from the same facilities as they go to outreach. Not that in Eswatini majority of TB patients are co-infected with HIV
Nicholas Kisyeri
01:40:48
...NOTE THAT...
Anna Grimsrud, International AIDS Society
01:40:50
Hi Patrick -great question. In many countries, there are already supportive policies for integration. So first it would be to check the policies around integration and see if it’s a policy barrier, or a challenge with implementation.
morgen muzondo
01:41:46
I might have missed, using the community approach of DDD, how do you maintain privacy and confidentiality issues at PUP
Caitlin Corneliess
01:41:59
Hi Jane, thanks for your question on DMPA-SC, the unit does not need any refrigeration and should be stable even in hot climates. For expiration dates, those providing the units will monitor for expiration prior to dispensing.
Jeanne Marie Francine KAREMERA
01:42:48
Please share how you follow side effects of the injections
Jane Mwangi
01:43:41
for DMPA-SC injection 3 months supply. How does one identify the expiry date of a product at home as the individual uniject do not have the expiry date printed on them. Are there additional labelling of the 3 moth MDD? How is the storage conditions maintained in very hot and humid areas e.g. Soroti (Uganda), when one does not have a refrigerator? This might affect the efficacy of the drug
Caitlin Corneliess
01:44:21
For DMPA-SC side effects, patients should be counseled before using the method on what to expect for side effects, mainly some bleeding can occur. Those providing should counsel so women know to expect this. Side effect information is also covered in job aids and videos easily accessible by clients.
Sarah Dixon
01:44:28
To register for our next session please click here: https://bit.ly/3p6311f
Hannah Marqusee
01:45:04
Thanks to all speakers and great job!
Anna Grimsrud, International AIDS Society
01:45:09
Thanks all - have another call now so will sign off. Hope we can all share slides and get emails of the panellists to talk more. Have a good week!